$AFCG
Advanced Flower Capital Inc. Stock $afcg

$afcg Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000182252323000006 Filed on March 07, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$16.83M	$19.70M	$75.13M
YoY Change	-3.18%	51.4%	100.55%
Cost Of Revenue	$3.704M	$3.892M	$15.77M
YoY Change	-3.72%	37.86%	89.45%
Gross Profit	$13.10M	$15.81M	$59.37M
YoY Change	-3.23%	55.16%	103.72%
Gross Profit Margin	77.84%	80.25%	79.02%
Selling, General & Admin	$2.708M	$2.028M	$7.640M
YoY Change	6.86%	22.13%	25.72%
% of Gross Profit	20.67%	12.83%	12.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$6.412M	$2.028M	$23.41M
YoY Change	0.48%	22.13%	62.55%
Operating Profit	$6.690M	$13.78M	$35.96M
YoY Change	-6.53%	61.59%	143.93%
Interest Expense	$1.668M	-$2.031M	$6.814M
YoY Change	-1.88%	1050.5%	504.7%
% of Operating Profit	24.94%	-14.74%	18.95%
Other Income/Expense, Net	-$702.4K	-$8.137M	-$11.18M
YoY Change	-22.39%	537.3%	321.9%
Pretax Income	$10.20M	$3.615M	$36.96M
YoY Change	0.2%	-48.92%	75.7%
Income Tax	$175.1K	$676.6K	$1.000M
% Of Pretax Income	1.72%	18.72%	2.71%
Net Earnings	$10.03M	$2.938M	$35.93M
YoY Change	-1.35%	-58.27%	71.1%
Net Earnings / Revenue	59.56%	14.91%	47.82%
Basic Earnings Per Share	$0.49		$1.80
Diluted Earnings Per Share	$0.49	$0.14	$1.79
COMMON SHARES
Basic Shares Outstanding	20.49M shares	20.36M shares	19.84M shares
Diluted Shares Outstanding	20.49M shares		19.96M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$80.61M	$140.4M	$140.4M
YoY Change	26.71%	12.17%	28.49%
Cash & Equivalents	$80.61M	$140.4M	$140.4M
Short-Term Investments		$0.00
Other Short-Term Assets	$420.2K	$460.8K	$460.8K
YoY Change	-30.46%	-51.45%	-51.45%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$81.03M	$140.8M	$140.8M
YoY Change	26.17%	27.8%	27.8%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets
YoY Change
Total Long-Term Assets	$366.8M	$378.3M	$378.3M
YoY Change	-5.91%	6.68%	6.68%
TOTAL ASSETS
Total Short-Term Assets	$81.03M	$140.8M	$140.8M
Total Long-Term Assets	$366.8M	$378.3M	$378.3M
Total Assets	$447.8M	$519.2M	$519.2M
YoY Change	-1.37%	11.69%	11.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.611M	$836.6K	$836.6K
YoY Change	-0.28%	-45.28%	-45.28%
Accrued Expenses	$8.698M	$9.973M	$9.973M
YoY Change	11.93%	0.52%	11.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$21.80M	$82.23M	$82.23M
YoY Change	7.57%	-13.0%	-12.08%
LONG-TERM LIABILITIES
Long-Term Debt	$87.57M	$97.13M	$97.13M
YoY Change	-9.41%	0.58%	0.58%
Other Long-Term Liabilities	$585.8K	$754.1K	$754.1K
YoY Change	-6.89%	10.39%	-54.98%
Total Long-Term Liabilities	$88.15M	$97.89M	$97.89M
YoY Change	-9.39%	0.65%	-0.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.80M	$82.23M	$82.23M
Total Long-Term Liabilities	$88.15M	$97.89M	$97.89M
Total Liabilities	$110.0M	$180.1M	$180.1M
YoY Change	-6.47%	-6.08%	-6.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.41M	-$9.962M
YoY Change		811.56%
Common Stock	$204.9K	$203.6K
YoY Change		24.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$337.9M	$339.1M	$339.1M
YoY Change
Total Liabilities & Shareholders Equity	$447.8M	$519.2M	$519.2M
YoY Change	-1.37%	11.69%	11.69%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$10.03M	$2.938M	$35.93M
YoY Change	-1.35%	-58.27%	71.1%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$4.383M	$3.866M	$31.32M
YoY Change	-6.06%	100.01%	228.37%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$14.99M	$52.18M	-$16.34M
YoY Change	-149.89%	-141.09%	-93.42%
Cash From Investing Activities	$14.99M	$52.18M	-$16.34M
YoY Change	-149.89%	-141.09%	-93.42%
FINANCING ACTIVITIES
Cash Dividend Paid			$41.62M
YoY Change			189.23%
Common Stock Issuance & Retirement, Net			$75.06M
YoY Change			-59.54%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$79.14M	48.01M	$16.15M
YoY Change	290.85%	-70.78%	-95.23%
NET CHANGE
Cash From Operating Activities	$4.383M	3.866M	$31.32M
Cash From Investing Activities	$14.99M	52.18M	-$16.34M
Cash From Financing Activities	-$79.14M	48.01M	$16.15M
Net Change In Cash	-$59.77M	104.1M	$31.13M
YoY Change	30.98%	164.96%	-68.76%
FREE CASH FLOW
Cash From Operating Activities	$4.383M	$3.866M	$31.32M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001822523
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39995
CY2022	dei	Entity Registrant Name EntityRegistrantName	AFC GAMMA, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1807125
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	525 Okeechobee Blvd., Suite 1650
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
CY2022	dei	City Area Code CityAreaCode	561
CY2022	dei	Local Phone Number LocalPhoneNumber	510-2390
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2022	dei	Trading Symbol TradingSymbol	AFCG
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	239468198	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20489234	shares
CY2022	dei	Auditor Name AuditorName	CohnReznick LLP
CY2022	dei	Auditor Firm AuditorFirmId	596
CY2022	dei	Auditor Location AuditorLocation	Baltimore, Maryland
CY2022Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	100635985	usd
CY2021Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	74913157	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
CY2021Q4	afcg	Available For Sale Debt Securities At Carrying Value AvailableForSaleDebtSecuritiesAtCarryingValue	16050000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15881250	usd
CY2022Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	285177112	usd
CY2021Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	257163496	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2220653	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2530588	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13538077	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	2431558	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	273859688	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	257262526	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	140372841	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109246048	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	5257475	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	4412938	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	460844	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	949279	usd
CY2022Q4	us-gaap	Assets Assets	519176899	usd
CY2021Q4	us-gaap	Assets Assets	464848360	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3200944	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4782271	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1036667	usd
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	991840	usd
CY2022Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	18146	usd
CY2021Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11403840	usd
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	8221406	usd
CY2022Q4	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	754128	usd
CY2021Q4	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	683177	usd
CY2022Q4	us-gaap	Management Fee Payable ManagementFeePayable	3891734	usd
CY2021Q4	us-gaap	Management Fee Payable ManagementFeePayable	2823044	usd
CY2022Q4	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	1843652	usd
CY2021Q4	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	1324457	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	836642	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1528980	usd
CY2022Q4	us-gaap	Senior Notes SeniorNotes	97131777	usd
CY2021Q4	us-gaap	Senior Notes SeniorNotes	96572656	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	60000000	usd
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	74845355	usd
CY2022Q4	us-gaap	Liabilities Liabilities	180117530	usd
CY2021Q4	us-gaap	Liabilities Liabilities	191773186	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	125	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	125	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	125	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	125	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20364000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20364000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16442812	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16442812	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	203640	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	163866	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	348817914	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	274172934	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-168750	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9962186	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1092877	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	339059369	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	273075174	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	519176899	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	464848360	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	81498717	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	38140487	usd
CY2022	us-gaap	Interest Expense InterestExpense	6814075	usd
CY2021	us-gaap	Interest Expense InterestExpense	1126846	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	74684642	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	37013641	usd
CY2021	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	1785916	usd
CY2022	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	1029315	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	15765250	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	8321512	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4699676	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3212785	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1338469	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1745872	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1601961	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	1118291	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	23405356	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	14398460	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	11177470	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	2649338	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3593095	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	619821	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	36958721	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21035664	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1026324	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35167	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	35932397	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	21000497	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.80
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.57
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.79
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.52
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19842222	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13373778	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19957737	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13808845	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	35932397	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	21000497	usd
CY2022	afcg	Oci Debt Securities Available For Sale Reversal Of Unrealized Holding Gain Loss Before Adjustment After Tax OCIDebtSecuritiesAvailableForSaleReversalOfUnrealizedHoldingGainLossBeforeAdjustmentAfterTax	168750	usd
CY2021	afcg	Oci Debt Securities Available For Sale Reversal Of Unrealized Holding Gain Loss Before Adjustment After Tax OCIDebtSecuritiesAvailableForSaleReversalOfUnrealizedHoldingGainLossBeforeAdjustmentAfterTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-168750	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-168750	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	36101147	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	20831747	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	273075174	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	73346205	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1338549	usd
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	2.23
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	44786706	usd
CY2022	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	120
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	15000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	35932397	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	339059369	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	91647712	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	181460937	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1745872	usd
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.67
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	22596094	usd
CY2021	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	120
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	15000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-168750	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	21000497	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	273075174	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	35932397	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	21000497	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	11177470	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	2649338	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3593095	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	619821	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	11763696	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	5584311	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1338469	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1745872	usd
CY2022	afcg	Payment In Kind Interest PaymentInKindInterest	8369127	usd
CY2021	afcg	Payment In Kind Interest PaymentInKindInterest	4534370	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	844537	usd
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	3485646	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-859203	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	877184	usd
CY2022	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	2031327	usd
CY2021	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	5993947	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	44827	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	991840	usd
CY2022	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	1068690	usd
CY2021	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	2600917	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	519195	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	16050000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	773786	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-674192	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1186585	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31321973	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9538562	usd
CY2022	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	162885750	usd
CY2021	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	272583787	usd
CY2022	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	usd
CY2021	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	2313130	usd
CY2022	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	120042065	usd
CY2021	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	22412569	usd
CY2022	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	10600000	usd
CY2021	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	15450000	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	15900000	usd
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16343685	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-248458088	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75057650	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	185501294	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1711365	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4040357	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	578508	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3529495	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	100000000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	60000000	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	75000000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	41619272	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	14389688	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	75000000	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16148505	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	338541754	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	31126793	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	99622228	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109246048	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9623820	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140372841	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109246048	usd
CY2022	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	450000	usd
CY2021	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	9450468	usd
CY2022	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	7764875	usd
CY2021	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	15021624	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-168750	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11403840	usd
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	8221406	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5847743	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	952524	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	35167	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, loans and interest receivable. The Company places its cash and cash equivalents with financial institutions, and, at times, cash held exceeds the Federal Deposit Insurance Corporation insured limit. The Company and the Company’s Manager seek to manage this credit risk by monitoring the financial institutions and their ability to continue in business for the foreseeable future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has exposure to credit risk on its loans and interest receivable. The Company and the Company’s Manager seek to manage credit risk by performing due diligence prior to origination or acquisition and through the use of non-recourse financing, when and where available and appropriate.</span></div>
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	15900000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value and current expected credit losses.</span></div>
CY2021	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	3	loan
CY2022	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	3	loan
CY2022Q4	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	104300000	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	75900000	usd
CY2022Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	102400000	usd
CY2021Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	77600000	usd
CY2022	afcg	Loans Held For Investment At Fair Value Funded Of Outstanding Principal LoansHeldForInvestmentAtFairValueFundedOfOutstandingPrincipal	26600000	usd
CY2022	afcg	Loans Held For Investment Repayment Of Outstanding Principal Amount LoansHeldForInvestmentRepaymentOfOutstandingPrincipalAmount	6500000	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2022Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	100635985	usd
CY2022Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	102376546	usd
CY2022	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P1Y2M12D
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
CY2021Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	74913157	usd
CY2021Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	77630742	usd
CY2021	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P2Y2M12D
CY2021Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	77630742	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	2717584	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	2183161	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
CY2022	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-3593095	usd
CY2022	afcg	Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-3593095	usd
CY2022	afcg	Loans Held For Investment At Fair Value Outstanding Principal New Fundings LoansHeldForInvestmentAtFairValueOutstandingPrincipalNewFundings	26605796	usd
CY2022	afcg	Loans Held For Investment At Fair Value Original Issue Discount New Funding LoansHeldForInvestmentAtFairValueOriginalIssueDiscountNewFunding	479275	usd
CY2022	afcg	Loans Held For Investment At Fair Value New Funding LoansHeldForInvestmentAtFairValueNewFunding	26126521	usd
CY2022	afcg	Loans Held For Investment At Fair Value Outstanding Principal Repayments LoansHeldForInvestmentAtFairValueOutstandingPrincipalRepayments	5397191	usd
CY2022	afcg	Loans Held For Investment At Fair Value Repayments LoansHeldForInvestmentAtFairValueRepayments	5397191	usd
CY2022	afcg	Loans Held For Investment At Fair Value Outstanding Principal Loan Amortization LoansHeldForInvestmentAtFairValueOutstandingPrincipalLoanAmortization	1089776	usd
CY2022	afcg	Loans Held For Investment At Fair Value Loan Amortization LoansHeldForInvestmentAtFairValueLoanAmortization	1089776	usd
CY2022	afcg	Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount	1456298	usd
CY2022	afcg	Loans Held For Investment At Fair Value Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount	1456298	usd
CY2022	afcg	Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest	4626975	usd
CY2022	afcg	Loans Held For Investment At Fair Value Payment In Kind Interest LoansHeldForInvestmentAtFairValuePaymentInKindInterest	4626975	usd
CY2022Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	102376546	usd
CY2022Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	1740561	usd
CY2022Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	-1409934	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2020Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	50831235	usd
CY2020Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	3836524	usd
CY2020Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	1563340	usd
CY2020Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	48558051	usd
CY2021	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	619821	usd
CY2021	afcg	Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	619821	usd
CY2021	afcg	Loans Held For Investment At Fair Value Outstanding Principal New Fundings LoansHeldForInvestmentAtFairValueOutstandingPrincipalNewFundings	37701104	usd
CY2021	afcg	Loans Held For Investment At Fair Value Original Issue Discount New Funding LoansHeldForInvestmentAtFairValueOriginalIssueDiscountNewFunding	1130623	usd
CY2021	afcg	Loans Held For Investment At Fair Value New Funding LoansHeldForInvestmentAtFairValueNewFunding	36570481	usd
CY2021	afcg	Loans Held For Investment At Fair Value Outstanding Principal Repayments LoansHeldForInvestmentAtFairValueOutstandingPrincipalRepayments	12000000	usd
CY2021	afcg	Loans Held For Investment At Fair Value Repayments LoansHeldForInvestmentAtFairValueRepayments	12000000	usd
CY2021	afcg	Loans Held For Investment At Fair Value Outstanding Principal Loan Amortization LoansHeldForInvestmentAtFairValueOutstandingPrincipalLoanAmortization	1093659	usd
CY2021	afcg	Loans Held For Investment At Fair Value Loan Amortization LoansHeldForInvestmentAtFairValueLoanAmortization	1093659	usd
CY2021	afcg	Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount	2249563	usd
CY2021	afcg	Loans Held For Investment At Fair Value Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount	2249563	usd
CY2021	afcg	Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest	2192062	usd
CY2021Q4	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.48
CY2021	afcg	Loans Held For Investment At Fair Value Payment In Kind Interest LoansHeldForInvestmentAtFairValuePaymentInKindInterest	2192062	usd
CY2021Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	77630742	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	2717584	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	2183161	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2022Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	100635985	usd
CY2022Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	102376546	usd
CY2022	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	9	loan
CY2021	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	12	loan
CY2022Q4	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	338900000	usd
CY2021Q4	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	324300000	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	296600000	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	270800000	usd
CY2022	afcg	Loans Held For Investment At Carrying Value Outstanding Principal New Fundings LoansHeldForInvestmentAtCarryingValueOutstandingPrincipalNewFundings	173700000	usd
CY2022	afcg	Receivable With Imputed Interest Loan Repayments ReceivableWithImputedInterestLoanRepayments	151700000	usd
CY2022Q4	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.73
CY2022Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	296584529	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	11407417	usd
CY2022Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	285177112	usd
CY2022	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P3Y1M6D
CY2021Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	270841715	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13678219	usd
CY2021Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	257163496	usd
CY2021	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P3Y4M24D
CY2021Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	270841715	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13678219	usd
CY2021Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	257163496	usd
CY2022	afcg	Receivable With Imputed Interest New Funding Face Amount ReceivableWithImputedInterestNewFundingFaceAmount	173685505	usd
CY2022	afcg	Receivable With Imputed Interest Discount On New Funding ReceivableWithImputedInterestDiscountOnNewFunding	8035600	usd
CY2022	afcg	Receivable With Imputed Interest New Funding Net Amount ReceivableWithImputedInterestNewFundingNetAmount	165649905	usd
CY2022	afcg	Receivable With Accretion Of Original Issue Discount Premium ReceivableWithAccretionOfOriginalIssueDiscountPremium	10306402	usd
CY2022	afcg	Accretion Of Original Issue Discount Net Amount AccretionOfOriginalIssueDiscountNetAmount	10306402	usd
CY2022	afcg	Receivable With Imputed Interest Loan Repayments Face Amount ReceivableWithImputedInterestLoanRepaymentsFaceAmount	138807472	usd
CY2022	afcg	Receivable With Imputed Interest Loan Repayments Face Amount ReceivableWithImputedInterestLoanRepaymentsFaceAmount	138807472	usd
CY2022	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	10000000	usd
CY2022	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	10000000	usd
CY2022	afcg	Receivable With Paid In Kind Interest Face Amount ReceivableWithPaidInKindInterestFaceAmount	3715966	usd
CY2022	afcg	Receivable With Paid In Kind Interest Face Amount ReceivableWithPaidInKindInterestFaceAmount	3715966	usd
CY2022	afcg	Receivable With Imputed Interest Amortization Payments ReceivableWithImputedInterestAmortizationPayments	2851185	usd
CY2022	afcg	Receivable With Imputed Interest Amortization Payments ReceivableWithImputedInterestAmortizationPayments	2851185	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	296584529	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	11407417	usd
CY2022Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	285177112	usd
CY2020Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	33907763	usd
CY2020Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	2070732	usd
CY2020Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	31837031	usd
CY2021	afcg	Receivable With Imputed Interest New Funding Face Amount ReceivableWithImputedInterestNewFundingFaceAmount	249591644	usd
CY2021	afcg	Receivable With Imputed Interest Discount On New Funding ReceivableWithImputedInterestDiscountOnNewFunding	14941001	usd
CY2021	afcg	Receivable With Imputed Interest New Funding Net Amount ReceivableWithImputedInterestNewFundingNetAmount	234650643	usd
CY2021	afcg	Receivable With Accretion Of Original Issue Discount Premium ReceivableWithAccretionOfOriginalIssueDiscountPremium	3333514	usd
CY2021	afcg	Accretion Of Original Issue Discount Net Amount AccretionOfOriginalIssueDiscountNetAmount	3333514	usd
CY2021	afcg	Receivable With Imputed Interest Realized Gain On Sale Of Loans Face Amount ReceivableWithImputedInterestRealizedGainOnSaleOfLoansFaceAmount	450000	usd
CY2021	afcg	Receivable With Imputed Interest Realized Gain On Sale Of Loans Face Amount ReceivableWithImputedInterestRealizedGainOnSaleOfLoansFaceAmount	450000	usd
CY2021	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	15450000	usd
CY2021	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	15450000	usd
CY2021	afcg	Receivable With Paid In Kind Interest Face Amount ReceivableWithPaidInKindInterestFaceAmount	2342308	usd
CY2021	afcg	Receivable With Paid In Kind Interest Face Amount ReceivableWithPaidInKindInterestFaceAmount	2342308	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	270841715	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13678219	usd
CY2021Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	257163496	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	296584529	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	11407417	usd
CY2022Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	285177112	usd
CY2021Q4	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2022Q4	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2022Q4	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000	usd
CY2021Q4	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000	usd
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2200000	usd
CY2021Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2500000	usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	300000	usd
CY2021Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2533266	usd
CY2021Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	2678	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2530588	usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	337114	usd
CY2022	afcg	Payments On Loans Receivable Carrying Value PaymentsOnLoansReceivableCarryingValue	337114	usd
CY2022	afcg	Accretion Of Original Issue Discount AccretionOfOriginalIssueDiscount	992	usd
CY2022	afcg	Accretion Of Original Issue Discount At Carrying Value AccretionOfOriginalIssueDiscountAtCarryingValue	992	usd
CY2022	afcg	Paid In Kind Interest Principal PaidInKindInterestPrincipal	26187	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	26187	usd
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2222339	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1686	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2220653	usd
CY2020Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	3352176	usd
CY2020Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	3913	usd
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	3348263	usd
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	818910	usd
CY2021	afcg	Payments On Loans Receivable Carrying Value PaymentsOnLoansReceivableCarryingValue	818910	usd
CY2021	afcg	Accretion Of Original Issue Discount AccretionOfOriginalIssueDiscount	1235	usd
CY2021	afcg	Accretion Of Original Issue Discount At Carrying Value AccretionOfOriginalIssueDiscountAtCarryingValue	1235	usd
CY2021Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2533266	usd
CY2021Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	2678	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2530588	usd
CY2022Q4	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	80548393	usd
CY2022Q4	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	181607278	usd
CY2022Q4	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	25242094	usd
CY2022Q4	afcg	Loans Held For Investment And Financing Receivable Before Allowance For Credit Loss LoansHeldForInvestmentAndFinancingReceivableBeforeAllowanceForCreditLoss	287397765	usd
CY2022Q4	afcg	Interest Receivables InterestReceivables	3722134	usd
CY2021Q4	afcg	Interest Receivables InterestReceivables	3562566	usd
CY2022Q4	afcg	Payment In Kind Receivable PaymentInKindReceivable	1409678	usd
CY2021Q4	afcg	Payment In Kind Receivable PaymentInKindReceivable	554357	usd
CY2022Q4	afcg	Unused Fees Receivable UnusedFeesReceivable	125663	usd
CY2021Q4	afcg	Unused Fees Receivable UnusedFeesReceivable	296015	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	5257475	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	4412938	usd
CY2022	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	3	loan
CY2021	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	7	loan
CY2022	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	14200000	usd
CY2021	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	6000000	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4782271	usd
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1325750	usd
CY2022	afcg	New Reserves Interest NewReservesInterest	12648888	usd
CY2021	afcg	New Reserves Interest NewReservesInterest	9450468	usd
CY2022	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	14230215	usd
CY2021	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	5993947	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3200944	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4782271	usd
CY2022	afcg	Debt Instrument Debt Service Coverage Ratio DebtInstrumentDebtServiceCoverageRatio	0.015
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	5807152	usd
CY2022	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	85417	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	921506	usd
CY2022	us-gaap	Interest Expense InterestExpense	6814075	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	962153	usd
CY2021	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	29687	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	135006	usd
CY2021	us-gaap	Interest Expense InterestExpense	1126846	usd
CY2022Q4	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	447101864	usd
CY2021Q4	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	419198125	usd
CY2022Q4	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	401476418	usd
CY2021Q4	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	363659505	usd
CY2022Q4	us-gaap	Contractual Obligation ContractualObligation	45625446	usd
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	55538620	usd
CY2021Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	123900000	usd
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	afcg	Shelf Registration Maximum Amount Of Offering For Common Stock ShelfRegistrationMaximumAmountOfOfferingForCommonStock	1000000000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.18
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	293420	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	183114	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	2081212	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1449518	shares
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5511	shares
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	88749	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	28396	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2280372	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604236	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1300000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1700000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604236	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	742000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.46
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5511	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.90
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	60353	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.15
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2280372	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	926898	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.91
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	689200	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.31
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	11862	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.01
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604236	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2022	us-gaap	Net Income Loss NetIncomeLoss	35932397	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	21000497	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	15000	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	15000	usd
CY2022	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	-135299	usd
CY2021	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	-24203	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	35782098	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	20961294	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19842222	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13373778	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	115515	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	435067	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19957737	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13808845	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.80
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.57
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.79
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.52
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1401200	shares
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	73000	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	73000	usd
CY2022	afcg	Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains	0.04
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	99226051	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
CY2022	afcg	Debt Securities Held At Fair Value Realized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueRealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	0	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	77096319	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15900000	usd
CY2021	afcg	Debt Securities Held At Fair Value Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueChangeInAccumulatedOtherComprehensiveIncome	-200000	usd
CY2021Q4	afcg	Debt Securities Held At Fair Value Outstanding Principal Amount DebtSecuritiesHeldAtFairValueOutstandingPrincipalAmount	15000000	usd
CY2021Q4	afcg	Debt Securities Held At Fair Value Original Issue Discount DebtSecuritiesHeldAtFairValueOriginalIssueDiscount	1050000	usd
CY2021Q4	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses DebtSecuritiesHeldAtFairValueUnrealizedGainsLosses	-168750	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15881250	usd
CY2022	afcg	Debt Securities Held At Fair Value Outstanding Principal Change In Realized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueOutstandingPrincipalChangeInRealizedGainsLossesOnLoansAtFairValueNet	0	usd
CY2022	afcg	Debt Securities Held At Fair Value Original Issue Discount Realized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueOriginalIssueDiscountRealizedGainsLossesOnLoansAtFairValueNet	-150000	usd
CY2022	afcg	Debt Securities Held At Fair Value Change In Realized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueChangeInRealizedGainsLossesOnLoansAtFairValueNet	-150000	usd
CY2022	afcg	Debt Securities Held At Fair Value Value Outstanding Principal Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueValueOutstandingPrincipalChangeInAccumulatedOtherComprehensiveIncome	0	usd
CY2022	afcg	Debt Securities Held At Fair Value Original Issue Discount Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueOriginalIssueDiscountChangeInAccumulatedOtherComprehensiveIncome	0	usd
CY2022	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueUnrealizedGainsLossesChangeInAccumulatedOtherComprehensiveIncome	-168750	usd
CY2022	afcg	Debt Securities Held At Fair Value Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueChangeInAccumulatedOtherComprehensiveIncome	-168750	usd
CY2022	afcg	Debt Securities Held At Fair Value Value Outstanding Principal Sale Of Securities DebtSecuritiesHeldAtFairValueValueOutstandingPrincipalSaleOfSecurities	15000000	usd
CY2022	afcg	Debt Securities Held At Fair Value Original Issue Discount Sale Of Securities DebtSecuritiesHeldAtFairValueOriginalIssueDiscountSaleOfSecurities	900000	usd
CY2022	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses Sale Of Securities DebtSecuritiesHeldAtFairValueUnrealizedGainsLossesSaleOfSecurities	0	usd
CY2022	afcg	Debt Securities Held At Fair Value Sale Of Securities DebtSecuritiesHeldAtFairValueSaleOfSecurities	15900000	usd
CY2022Q4	afcg	Debt Securities Held At Fair Value Outstanding Principal Amount DebtSecuritiesHeldAtFairValueOutstandingPrincipalAmount	0	usd
CY2022Q4	afcg	Debt Securities Held At Fair Value Original Issue Discount DebtSecuritiesHeldAtFairValueOriginalIssueDiscount	0	usd
CY2022Q4	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses DebtSecuritiesHeldAtFairValueUnrealizedGainsLosses	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2022Q4	afcg	Debt Securities Fair Value Disclosure DebtSecuritiesFairValueDisclosure	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2021Q4	afcg	Debt Securities Fair Value Disclosure DebtSecuritiesFairValueDisclosure	15881250	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15881250	usd
CY2022	afcg	Incentive Compensation IncentiveCompensation	12300000	usd
CY2021	afcg	Incentive Compensation IncentiveCompensation	6000000	usd
CY2022	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	5213535	usd
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	3340123	usd
CY2022	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	1785916	usd
CY2021	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	1029315	usd
CY2022	afcg	Related Party Transaction Base Management Fees Net RelatedPartyTransactionBaseManagementFeesNet	3427619	usd
CY2021	afcg	Related Party Transaction Base Management Fees Net RelatedPartyTransactionBaseManagementFeesNet	2310808	usd
CY2022	afcg	Incentive Compensation IncentiveCompensation	12337631	usd
CY2021	afcg	Incentive Compensation IncentiveCompensation	6010704	usd
CY2022	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	3976312	usd
CY2021	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	2319074	usd
CY2022	us-gaap	Related Party Costs RelatedPartyCosts	19741562	usd
CY2021	us-gaap	Related Party Costs RelatedPartyCosts	10640586	usd
CY2022	afcg	Number Of Co Invested Loans Held NumberOfCoInvestedLoansHeld	4	loan
CY2021	afcg	Sale Of Assigned Rights For Additional Original Issue Discount And Accreted SaleOfAssignedRightsForAdditionalOriginalIssueDiscountAndAccreted	2300000	usd
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.67
CY2021	afcg	Taxable Ordinary Income Per Share TaxableOrdinaryIncomePerShare	1.67
CY2021	afcg	Return Of Capital Distribution Per Share ReturnOfCapitalDistributionPerShare	0
CY2021	afcg	Section199 A Dividends Section199ADividends	1.67
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	2.23
CY2022	afcg	Taxable Ordinary Income Per Share TaxableOrdinaryIncomePerShare	2.23
CY2022	afcg	Return Of Capital Distribution Per Share ReturnOfCapitalDistributionPerShare	0
CY2022	afcg	Section199 A Dividends Section199ADividends	2.23

Files In Submission

Name	View Source	Status
0001822523-23-000006-index-headers.html	Edgar Link	pending
0001822523-23-000006-index.html	Edgar Link	pending
0001822523-23-000006.txt	Edgar Link	pending
0001822523-23-000006-xbrl.zip	Edgar Link	pending
afcg-20221231.htm	Edgar Link	pending
afcg-20221231.xsd	Edgar Link	pending
afcg-20221231xexx311.htm	Edgar Link	pending
afcg-20221231xexx312.htm	Edgar Link	pending
afcg-20221231xexx321.htm	Edgar Link	pending
afcg-20221231xexx322.htm	Edgar Link	pending
afcg-20221231_g1.jpg	Edgar Link	pending
afcg-20221231_g2.jpg	Edgar Link	pending
afcg-thirdamendmenttoarman.htm	Edgar Link	pending
consentafcg10-k.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
afcg-20221231_def.xml	Edgar Link	unprocessable
afcg-20221231_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
afcg-20221231_cal.xml	Edgar Link	unprocessable
afcg-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
afcg-20221231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AFCG
Advanced Flower Capital Inc. Stock $afcg

2023 Q1 Form 10-K Financial Statement

#000182252323000006 Filed on March 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG Advanced Flower Capital Inc. Stock $afcg

2023 Q1 Form 10-K Financial Statement

#000182252323000006 Filed on March 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG
Advanced Flower Capital Inc. Stock $afcg